S-1: Ontrak Seeks to Raise Capital Through Common Stock Offering Under Warrants

Ontrak, Inc. is offering up to 6,449,481 shares of common stock issuable upon the exercise of outstanding warrants to raise capital for general corporate purposes.

Summary

• Ontrak, Inc., an AI-powered behavioral healthcare company, has filed a registration statement on Form S-1 to offer up to 6,449,481 shares of its common stock.
• These shares are issuable upon the exercise of outstanding Public Offering Warrants issued in November 2023.
• The company intends to use the proceeds from the offering for general corporate purposes, including working capital.
• As of October 11, 2024, the closing price of Ontrak's common stock was $2.44 per share.
• The exercise price of the Public Offering Warrants was reduced to either $2.25 or $2.08 following a 1-for-15 reverse stock split in September 2024.
• The company has been subject to Nasdaq listing requirements, including the minimum bid price rule, and is under a Discretionary Panel Monitor for one year from October 7, 2024.
• Ontrak has also entered into a Keep Well Agreement with Acuitas Capital LLC, under which it has issued senior secured convertible promissory notes.
• A health plan customer notified Ontrak of its intent not to continue using its services after December 2024, which represented 62% of Ontrak's revenue for the six months ended June 30, 2024.
• With remaining customers under contract, Ontrak expects annual revenues to be in the range of $9 million to $11 million.
• The company is pursuing new contracts with several active prospects, representing a potential annual revenue opportunity of $13 million to $15 million.

Sentiment

Score: 4

Explanation: The document presents a mixed sentiment. While there are potential revenue opportunities and the company has regained Nasdaq compliance, the loss of a major customer and the need for additional funding raise concerns.

Positives

• Ontrak is actively pursuing new contracts with several prospects, potentially generating $13 million to $15 million in annual revenue.
• The company has five active prospects in the late stage of the sales cycle.
• Ontrak has regained compliance with Nasdaq's minimum bid price rule as of October 7, 2024.
• The company has access to additional funding through the Keep Well Agreement with Acuitas Capital LLC.

Negatives

• A major customer, accounting for 62% of revenue for the six months ended June 30, 2024, will discontinue services after December 2024.
• Ontrak expects annual revenues to be in the range of $9 million to $11 million with remaining customers.
• The company is subject to a Discretionary Panel Monitor by Nasdaq for one year from October 7, 2024.
• There is no assurance that all or any portion of the Public Offering Warrants will be exercised.
• The company has incurred negative cash flows from operations since inception.

Risks

• Ontrak may not be able to comply with continued listing standards of Nasdaq, which could limit investors' ability to transact in its securities.
• Acuitas Group Holdings, LLC owns approximately 46% of Ontrak's outstanding common stock and beneficially owns approximately 95% of its common stock, giving it substantial influence over the company.
• Certain warrants contain anti-dilution provisions that could harm trading in Ontrak's common stock and make it difficult to obtain additional financing.
• The exercise of outstanding warrants and options may result in significant dilution to stockholders.
• Ontrak may need additional funding and cannot guarantee that it will find adequate sources of capital in the future.
• If Acuitas were to demand that all or a significant portion of the Demand Notes be paid in August 2025, the company may not have sufficient funds to repay the amounts due, which would have a material adverse effect on its business and raise substantial doubt about its ability to continue as a going concern.

Future Outlook

Ontrak aims to increase the number of members eligible for its solutions by signing new contracts and identifying more eligible members within existing customer contracts. The company is pursuing new contracts with several active prospects, representing a potential annual revenue opportunity of $13 million to $15 million.

Industry Context

The document does not provide specific details on how this announcement relates to broader industry trends or competitors. However, it highlights the company's focus on AI-powered and technology-enabled behavioral healthcare solutions, which aligns with the growing trend of leveraging technology to improve healthcare delivery and outcomes.

Related Party Transactions

• The Keep Well Agreement with Acuitas Capital LLC, an entity controlled by Terren S. Peizer, involves related-party transactions.

Stakeholder Impact

• Shareholders may experience dilution from the exercise of warrants and potential future equity issuances.
• Employees may be affected by the company's financial performance and strategic decisions.
• Customers may be impacted by changes in the company's service offerings and customer base.
• Creditors are subject to the company's ability to meet its financial obligations.

Next Steps

• Ontrak will continue to pursue new contracts with active prospects.
• The company will monitor its compliance with Nasdaq listing requirements.
• Ontrak will manage its financial obligations under the Keep Well Agreement with Acuitas Capital LLC.

Key Dates

Keywords

common stock, warrants, offering, Ontrak, Acuitas, Nasdaq, revenue, funding, dilution, compliance